Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Journal of Cancer
|
April 1, 2020
Effect of CELSR3 on the Cell Cycle and Apoptosis of Hepatocellular Carcinoma Cells
Zucheng Xie, Yiwu Dang, Huayu Wu, et al.
Nature Communications
|
June 24, 2026
Spatiotemporal flux breathing and topological sculpting in structured transverse orbital angular momentum lattices
Dawei Liu, Xingyuan Zhang, Yonghang Tai, et al.
Aging
|
February 6, 2020
Protein disulfide isomerases are promising targets for predicting the survival and tumor progression in glioma patients
Zhigang Peng, Yu Chen, Hui Cao, et al.
Journal of Cancer
|
March 14, 2022
Erratum: Effect of CELSR3 on the Cell Cycle and Apoptosis of Hepatocellular Carcinoma Cells: Erratum
Zucheng Xie, Yiwu Dang, Huayu Wu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 9, 2010
Targeted agents for chronic myelogenous leukemia: will that be the end of allogeneic bone marrow transplantation for that disease?
Yuzhen Liang, Yongrong Lai, Paul Schwarzenberger, et al.
Oncology Research
|
January 25, 2017
MicroRNA-148a Acts as a Tumor Suppressor in Osteosarcoma via Targeting Rho-Associated Coiled-Coil Kinase
HaiYan Yang, ZhiGang Peng, ZhenZhen Da, et al.
American Journal of Hematology
|
May 30, 2026
Treatment Patterns and Clinical Outcomes After Immunotherapy Failure in Patients With Natural Killer/T-Cell Lymphoma
Shenrui Bai, Yongping Song, Liang Wang, et al.
Cancer Immunology, Immunotherapy : CII
|
June 8, 2023
Efficacy and safety of geptanolimab (GB226) for relapsed/refractory primary mediastinal large B-cell lymphoma: an open-label phase II study (Gxplore-003)
Yuankai Shi, Jie Cui, Hui Zhou, et al.
Journal of Hematology & Oncology
|
April 27, 2025
A multicenter, open-label, single-arm, phase Ib clinical trial of HH2853 treatment in patients with relapsed and/or refractory peripheral T-cell lymphoma
Huangming Hong, Zegeng Chen, Mingzhi Zhang, et al.
American Journal of Hematology
|
August 27, 2021
Sequential P-GEMOX and radiotherapy for early-stage extranodal natural killer/T-cell lymphoma: A multicenter study
Yuchen Zhang, Shuyun Ma, Jun Cai, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Journal of Cancer
|
April 1, 2020
Effect of CELSR3 on the Cell Cycle and Apoptosis of Hepatocellular Carcinoma Cells
Zucheng Xie, Yiwu Dang, Huayu Wu, et al.
Nature Communications
|
June 24, 2026
Spatiotemporal flux breathing and topological sculpting in structured transverse orbital angular momentum lattices
Dawei Liu, Xingyuan Zhang, Yonghang Tai, et al.
Aging
|
February 6, 2020
Protein disulfide isomerases are promising targets for predicting the survival and tumor progression in glioma patients
Zhigang Peng, Yu Chen, Hui Cao, et al.
Journal of Cancer
|
March 14, 2022
Erratum: Effect of CELSR3 on the Cell Cycle and Apoptosis of Hepatocellular Carcinoma Cells: Erratum
Zucheng Xie, Yiwu Dang, Huayu Wu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 9, 2010
Targeted agents for chronic myelogenous leukemia: will that be the end of allogeneic bone marrow transplantation for that disease?
Yuzhen Liang, Yongrong Lai, Paul Schwarzenberger, et al.
Oncology Research
|
January 25, 2017
MicroRNA-148a Acts as a Tumor Suppressor in Osteosarcoma via Targeting Rho-Associated Coiled-Coil Kinase
HaiYan Yang, ZhiGang Peng, ZhenZhen Da, et al.
American Journal of Hematology
|
May 30, 2026
Treatment Patterns and Clinical Outcomes After Immunotherapy Failure in Patients With Natural Killer/T-Cell Lymphoma
Shenrui Bai, Yongping Song, Liang Wang, et al.
Cancer Immunology, Immunotherapy : CII
|
June 8, 2023
Efficacy and safety of geptanolimab (GB226) for relapsed/refractory primary mediastinal large B-cell lymphoma: an open-label phase II study (Gxplore-003)
Yuankai Shi, Jie Cui, Hui Zhou, et al.
Journal of Hematology & Oncology
|
April 27, 2025
A multicenter, open-label, single-arm, phase Ib clinical trial of HH2853 treatment in patients with relapsed and/or refractory peripheral T-cell lymphoma
Huangming Hong, Zegeng Chen, Mingzhi Zhang, et al.
American Journal of Hematology
|
August 27, 2021
Sequential P-GEMOX and radiotherapy for early-stage extranodal natural killer/T-cell lymphoma: A multicenter study
Yuchen Zhang, Shuyun Ma, Jun Cai, et al.
Page
of 7